POLYOMAVIRUS-ASSOCIATED NEPHROPATHY

This adverse event was reported 1306 times

These drugs are most commonly taken by patients reporting POLYOMAVIRUS-ASSOCIATED NEPHROPATHY:

# Drug Count
0 TACROLIMUS 1024
1 TACROLIMUS CAPSULES 924
2 MYCOPHENOLATE MOFETIL 802
3 PREDNISONE 432
4 PREDNISOLONE 347
5 METHYLPREDNISOLONE 282
6 BASILIXIMAB 253
7 MYCOPHENOLIC ACID 162
8 VALGANCICLOVIR 145
9 VALGANCICLOVIR HYDROCHLORIDE 145
See all common drugs associated with POLYOMAVIRUS-ASSOCIATED NEPHROPATHY

POLYOMAVIRUS-ASSOCIATED NEPHROPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE 1 0.0714
1 BASILIXIMAB 253 0.0341
2 CIDOFOVIR ANHYDROUS 27 0.0321
3 HUMAN IMMUNOGLOBULIN G 1 0.0270
4 TACROLIMUS CAPSULES 924 0.0145
5 EVEROLIMUS TABLETS 124 0.0142
6 VALGANCICLOVIR 145 0.0134
7 ANTI-THYMOCYTE GLOBULIN (RABBIT) 65 0.0110
8 TACROLIMUS 1024 0.0110
9 MYCOPHENOLATE MOFETIL 802 0.0107
See all drugs enriched for association with POLYOMAVIRUS-ASSOCIATED NEPHROPATHY